Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

Guido Rindi

doi:10.1093/annonc/mdv176

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

Guido Rindi

Risultato della ricerca: Contributo in rivista › Articolo in rivista

89 Citazioni (Scopus)

Abstract

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

Lingua originale	English
pagine (da-a)	1710-1714
Numero di pagine	5
Rivista	Annals of Oncology
DOI	https://doi.org/10.1093/annonc/mdv176
Stato di pubblicazione	Pubblicato - 2015

Keywords

cancer
colorectal

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1093/annonc/mdv176

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{3783aea9c0b64db19f031e94c29c6b35,

title = "Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.",

abstract = "Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial",

keywords = "cancer, colorectal, cancer, colorectal",

author = "Guido Rindi",

year = "2015",

doi = "10.1093/annonc/mdv176",

language = "English",

pages = "1710--1714",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

AU - Rindi, Guido

PY - 2015

Y1 - 2015

N2 - Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

AB - Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

KW - cancer

KW - colorectal

KW - cancer

KW - colorectal

UR - http://hdl.handle.net/10807/71192

U2 - 10.1093/annonc/mdv176

DO - 10.1093/annonc/mdv176

M3 - Article

SN - 0923-7534

SP - 1710

EP - 1714

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo